Eversept Partners as of Sept. 30, 2021
Portfolio Holdings for Eversept Partners
Eversept Partners holds 102 positions in its portfolio as reported in the September 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
United Therapeutics Corporation (UTHR) | 6.1 | $82M | 445k | 184.58 | |
Ascendis Pharma A/s Sponsored Adr (ASND) | 5.3 | $71M | 445k | 159.39 | |
Community Health Systems (CYH) | 5.2 | $70M | 6.0M | 11.70 | |
Horizon Therapeutics Pub L SHS | 5.2 | $70M | 635k | 109.54 | |
Acceleron Pharma | 4.5 | $60M | 350k | 172.10 | |
Amarin Corp Spons Adr New (AMRN) | 4.4 | $59M | 12M | 5.10 | |
Astrazeneca Sponsored Adr (AZN) | 4.0 | $54M | 891k | 60.06 | |
Avantor (AVTR) | 4.0 | $53M | 1.3M | 40.90 | |
Ark Etf Tr Genomic Rev Etf (ARKG) | 3.9 | $52M | 690k | 74.72 | |
Danaher Corporation (DHR) | 3.4 | $45M | 148k | 304.64 | |
Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 2.7 | $37M | 6.8M | 5.34 | |
Laboratory Corp Amer Hldgs Com New (LH) | 2.7 | $36M | 128k | 281.44 | |
Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 2.6 | $35M | 3.6M | 9.74 | |
Envista Hldgs Corp (NVST) | 2.5 | $34M | 811k | 41.81 | |
Glaxosmithkline Call | 2.4 | $33M | 15k | 2173.37 | |
McKesson Corporation (MCK) | 2.4 | $32M | 162k | 199.67 | |
Bristol Myers Squibb (BMY) | 2.1 | $28M | 465k | 59.79 | |
Catalent (CTLT) | 1.8 | $25M | 184k | 133.07 | |
Icon SHS (ICLR) | 1.4 | $19M | 72k | 262.02 | |
Masimo Corporation (MASI) | 1.4 | $18M | 67k | 270.72 | |
Ortho Clinical Diagnostics H Ord Shs | 1.3 | $17M | 915k | 18.48 | |
R1 Rcm | 1.3 | $17M | 765k | 22.01 | |
Spdr S&p 500 Etf Tr Put | 1.2 | $16M | 1.0k | 16344.00 | |
Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 1.2 | $16M | 328k | 49.08 | |
Fate Therapeutics (FATE) | 1.2 | $16M | 261k | 59.27 | |
Glaxosmithkline Sponsored Adr | 1.2 | $15M | 402k | 38.37 | |
Ionis Pharmaceuticals (IONS) | 1.1 | $15M | 451k | 33.54 | |
Guardant Health (GH) | 0.9 | $13M | 100k | 125.01 | |
Natera (NTRA) | 0.9 | $13M | 112k | 111.44 | |
Sanofi Sponsored Adr (SNY) | 0.9 | $13M | 259k | 48.21 | |
Anthem (ELV) | 0.9 | $12M | 32k | 372.80 | |
Zogenix Com New | 0.9 | $12M | 775k | 15.19 | |
Taro Pharmaceutical Inds SHS (TARO) | 0.9 | $11M | 179k | 63.63 | |
Alnylam Pharmaceuticals (ALNY) | 0.8 | $11M | 59k | 188.81 | |
Exelixis (EXEL) | 0.8 | $11M | 516k | 21.14 | |
Magellan Health Com New | 0.7 | $9.9M | 105k | 94.55 | |
Astrazeneca Call | 0.7 | $9.6M | 2.6k | 3675.37 | |
Humana (HUM) | 0.7 | $9.4M | 24k | 389.94 | |
Hca Holdings (HCA) | 0.7 | $9.3M | 38k | 242.71 | |
Centene Corporation (CNC) | 0.7 | $8.8M | 141k | 62.31 | |
Intra Cellular Therapies (ITCI) | 0.6 | $8.6M | 231k | 37.28 | |
PerkinElmer (RVTY) | 0.6 | $8.2M | 47k | 173.30 | |
Nanostring Technologies (NSTGQ) | 0.6 | $8.1M | 169k | 48.01 | |
Healthequity (HQY) | 0.6 | $7.4M | 114k | 64.76 | |
Qiagen Nv Shs New | 0.6 | $7.4M | 143k | 51.68 | |
Community Health Sys Call | 0.5 | $7.2M | 11k | 672.30 | |
Irhythm Technologies (IRTC) | 0.5 | $6.7M | 114k | 58.56 | |
Gohealth Com Cl A | 0.5 | $6.3M | 1.3M | 5.03 | |
Horizon Therapeutics Pub L Call | 0.5 | $6.2M | 700.00 | 8855.71 | |
Teva Pharmaceutical Inds Call | 0.3 | $4.6M | 9.6k | 473.40 | |
Hill-Rom Holdings | 0.3 | $4.5M | 30k | 150.00 | |
Lexicon Pharmaceuticals Com New (LXRX) | 0.3 | $4.2M | 873k | 4.81 | |
Ark Etf Tr Innovation Etf (ARKK) | 0.3 | $3.9M | 35k | 110.54 | |
Rti Biologics | 0.3 | $3.8M | 3.5M | 1.09 | |
Hill-rom Hldgs Call | 0.3 | $3.5M | 294.00 | 12006.80 | |
Dex (DXCM) | 0.3 | $3.5M | 6.4k | 546.79 | |
Si-bone (SIBN) | 0.2 | $3.2M | 150k | 21.42 | |
Intuitive Surgical Com New (ISRG) | 0.2 | $3.1M | 3.1k | 994.28 | |
Evolent Health Cl A (EVH) | 0.2 | $3.1M | 100k | 31.00 | |
Karuna Therapeutics Ord | 0.2 | $3.1M | 25k | 122.32 | |
Agilent Technologies Inc C ommon (A) | 0.2 | $2.9M | 19k | 157.56 | |
Puma Biotechnology (PBYI) | 0.2 | $2.8M | 398k | 7.01 | |
Vertex Pharmaceuticals Call | 0.2 | $2.7M | 1.7k | 1582.80 | |
Miragen Therapeutics (VRDN) | 0.2 | $2.6M | 160k | 16.45 | |
Autolus Therapeutics Spon Ads (AUTL) | 0.2 | $2.6M | 398k | 6.55 | |
Liquidia Corporation Com New (LQDA) | 0.2 | $2.6M | 929k | 2.76 | |
Morphic Hldg (MORF) | 0.2 | $2.5M | 44k | 56.65 | |
Outset Med (OM) | 0.2 | $2.3M | 48k | 49.43 | |
Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.2 | $2.3M | 445k | 5.17 | |
HealthStream (HSTM) | 0.2 | $2.2M | 78k | 28.58 | |
Mereo Biopharma Group Ads (MREO) | 0.2 | $2.2M | 900k | 2.42 | |
Merck & Co Call | 0.2 | $2.2M | 487.00 | 4425.05 | |
Anaptysbio Inc Common (ANAB) | 0.2 | $2.1M | 78k | 27.12 | |
Avrobio Ord (AVRO) | 0.2 | $2.0M | 360k | 5.58 | |
Gossamer Bio (GOSS) | 0.1 | $1.9M | 150k | 12.57 | |
Editas Medicine Put | 0.1 | $1.8M | 500.00 | 3652.00 | |
Myomo Com New (MYO) | 0.1 | $1.8M | 150k | 11.89 | |
Argenx Se Sponsored Adr (ARGX) | 0.1 | $1.7M | 5.7k | 301.95 | |
Mirati Therapeutics | 0.1 | $1.7M | 9.4k | 176.91 | |
Iqvia Holdings (IQV) | 0.1 | $1.6M | 6.8k | 239.47 | |
Logicbio Therapeutics | 0.1 | $1.6M | 350k | 4.58 | |
Novavax Call | 0.1 | $1.6M | 100.00 | 16010.00 | |
Ac Immune Sa SHS (ACIU) | 0.1 | $1.5M | 222k | 6.71 | |
Magenta Therapeutics | 0.1 | $1.4M | 199k | 7.28 | |
Orchard Therapeutics Ads | 0.1 | $1.3M | 570k | 2.30 | |
Akoya Biosciences (AKYA) | 0.1 | $1.3M | 92k | 13.96 | |
Repligen Corporation (RGEN) | 0.1 | $1.3M | 4.4k | 288.96 | |
Assembly Biosciences | 0.1 | $1.2M | 350k | 3.48 | |
Heska Corp Com Restrc New | 0.1 | $1.2M | 4.5k | 258.56 | |
AMN Healthcare Services (AMN) | 0.1 | $1.1M | 10k | 114.80 | |
Cyclerion Therapeutics | 0.1 | $1.1M | 372k | 3.07 | |
Phasebio Pharmaceuticals (PHASQ) | 0.1 | $933k | 300k | 3.11 | |
Ensign (ENSG) | 0.1 | $779k | 10k | 74.93 | |
Eledon Pharmaceuticals (ELDN) | 0.1 | $705k | 114k | 6.18 | |
Milestone Pharmaceuticals (MIST) | 0.0 | $649k | 114k | 5.71 | |
Frequency Therapeutics Put | 0.0 | $477k | 679.00 | 702.50 | |
Deciphera Pharmaceuticals In Call | 0.0 | $447k | 187.00 | 2390.37 | |
Teligent Com New (TLGTQ) | 0.0 | $427k | 1.1M | 0.40 | |
Cross Country Healthcare (CCRN) | 0.0 | $425k | 20k | 21.25 | |
F-star Therapeutics | 0.0 | $366k | 50k | 7.33 | |
Frequency Therapeutics | 0.0 | $212k | 30k | 7.07 | |
Apellis Pharmaceuticals Call | 0.0 | $208k | 1.3k | 164.56 |